Location History:
- Arlington, MA (US) (2007 - 2013)
- Chevy Chase, MD (US) (2015 - 2020)
- Kensington, MD (US) (2024)
Company Filing History:
10 out of 2,893 
8 out of 1,209 
2 out of 1,309 
Years Active: 2007-2024
Title: The Innovative Contributions of Daphne Winifred Bell
Introduction
Daphne Winifred Bell is a prominent inventor based in Chevy Chase, Maryland. With an impressive portfolio of 10 patents, her contributions have significantly advanced the field of cancer treatment. Bell's innovative methodologies focus on enhancing the efficacy of therapies targeting the epidermal growth factor receptor.
Latest Patents
Among her latest patents, Bell has developed a groundbreaking method for determining the responsiveness of cancer to epidermal growth factor receptor (EGFR) targeting treatments. This method includes specific techniques and reagents that enable the detection of mutations associated with cancer responsiveness to EGFR-targeting drugs. The ability to identify these mutations allows healthcare professionals to administer treatments like gefitinib and erlotinib to patients who are most likely to benefit from these therapies.
Career Highlights
Daphne has built an extensive career, working with renowned institutions in the medical field, including The General Hospital Corporation and Dana-Farber Cancer Institute Inc. Her expertise in cancer research has positioned her as a key figure in developing effective cancer therapies.
Collaborations
Throughout her career, Bell has collaborated with notable colleagues, including Daniel Arie Haber and Jeffrey E. Settleman. These partnerships have been instrumental in advancing her research and enhancing the impact of her inventions within the oncology community.
Conclusion
Daphne Winifred Bell's innovative approach to cancer treatment through her patents and collaborations highlights her significant role in the medical field. Her dedication to improving patient outcomes continues to inspire and drive research forward, showcasing the potential of targeted therapies in the fight against cancer.